A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
AstraZeneca
Memorial Sloan Kettering Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ViroMissile, Inc.
Children's Oncology Group
Dana-Farber Cancer Institute
Children's Oncology Group
Washington University School of Medicine
Essen Biotech
St. Jude Children's Research Hospital
MacroGenics
University of Nebraska
University of Florida
Immatics US, Inc.
Degron Therapeutics Co.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
ImmVira Pharma Co. Ltd
Hadassah Medical Organization
Guangzhou FineImmune Biotechnology Co., LTD.
Institut Claudius Regaud
Azienda Ospedaliera di Padova
National Cancer Centre, Singapore
Centre Hospitalier Universitaire Vaudois
Stanford University
Sheffield Teaching Hospitals NHS Foundation Trust
BostonGene
GI Innovation, Inc.
Y-mAbs Therapeutics
European Organisation for Research and Treatment of Cancer - EORTC
Innolake Biopharm
N.N. Petrov National Medical Research Center of Oncology
Presage Biosciences
BioEclipse Therapeutics
Shanghai Yunying Medical Technology